EP2586459
VEGF mótlyfssamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.3.2006EP published:
24.5.2017EP application number:
13152402.7
EP translation filed:
9.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
21.3.2026Expiry date:
21.3.2026
Title:
VEGF ANTAGONIST FORMULATIONS
Timeline
Today
22.3.2006EP application
24.5.2017EP Publication
9.8.2017Translation submitted
15.9.2017Registration published
21.3.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, 10591-6707, Tarrytown, NY, US
Inventor
Name:
DIX, DanielAddress:
LaGrangeville, NY, US
Name:
FRYE, KellyAddress:
Mendham, NJ, US
Name:
KAUTZ, SusanAddress:
Albany, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
665125 PDate:
25.3.2005Country:
US
Classification
Categories:
A61K 38/17, A61K 47/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 19.2.2018
Expires: 21.3.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 19.2.2019
Expires: 21.3.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 15
Paid: 18.2.2020
Expires: 21.3.2021
Payer: Patice ehf.
Number: 16
Paid: 17.2.2021
Expires: 21.3.2022
Payer: Patice ehf.
Number: 17
Paid: 17.2.2022
Expires: 21.3.2023
Payer: Patice ehf.
Number: 18
Paid: 22.2.2023
Expires: 21.3.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 6.3.2024
Expires: 21.3.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 12.3.2025
Expires: 21.3.2026
Payer: Árnason Faktor ehf.